SPECC1L-ADORA2A
Description
The SPECC1L-ADORA2A (SPECC1L-ADORA2A readthrough (NMD candidate)) is a ncRNA gene located on chromosome 22.
The SPECC1L-ADORA2A fusion gene is a chimeric gene that results from a genetic rearrangement that combines portions of the SPECC1L and ADORA2A genes. This fusion gene encodes a protein that contains both the SPECC1L and ADORA2A domains. The function of the SPECC1L-ADORA2A fusion protein is not fully understood, but it is thought to be involved in cell signaling pathways. The fusion protein may have a role in regulating the activity of adenosine receptors, which are involved in a variety of physiological processes, including inflammation, neurotransmission, and cell proliferation.
The SPECC1L-ADORA2A fusion gene is a chimeric gene that results from a genetic rearrangement that combines portions of the SPECC1L and ADORA2A genes. This fusion gene encodes a protein that contains both the SPECC1L and ADORA2A domains. The function of the SPECC1L-ADORA2A fusion protein is not fully understood, but it is thought to be involved in cell signaling pathways. The fusion protein may have a role in regulating the activity of adenosine receptors, which are involved in a variety of physiological processes, including inflammation, neurotransmission, and cell proliferation.
SPECC1L-ADORA2A is also known as -.
Associated Diseases
- lethal omphalocele-cleft palate syndrome
- bifid uvula
- van der Woude syndrome 1
- Tessier number 4 facial cleft
- 2q33.1 microdeletion syndrome
- orofacial cleft 5
- dysraphism-cleft lip/palate-limb reduction defects syndrome
